Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Lee’s Pharmaceutical Holdings Limited ( (HK:0950) ) has issued an announcement.
Lee’s Pharmaceutical Holdings Limited has declared a final ordinary dividend of HKD 0.023 per share for the financial year ended 31 December 2025, reinforcing its commitment to delivering cash returns to shareholders. The dividend, denominated in Hong Kong dollars, is subject to shareholder approval at the annual general meeting scheduled for 21 May 2026.
Shares will trade ex-dividend on 27 May 2026, with the record date set for 1 June 2026 following a book closure from 29 May to 1 June. Eligible shareholders are expected to receive payment on 15 June 2026, a move that may signal management’s confidence in the company’s financial performance and provide income visibility for investors.
The most recent analyst rating on (HK:0950) stock is a Hold with a HK$1.50 price target. To see the full list of analyst forecasts on Lee’s Pharmaceutical Holdings Limited stock, see the HK:0950 Stock Forecast page.
More about Lee’s Pharmaceutical Holdings Limited
Lee’s Pharmaceutical Holdings Limited is a Hong Kong-listed company in the pharmaceutical sector. It focuses on developing, manufacturing and marketing pharmaceutical products, serving healthcare markets primarily through prescription medicines and related therapeutic solutions.
Average Trading Volume: 801,960
Technical Sentiment Signal: Sell
Current Market Cap: HK$777.3M
For a thorough assessment of 0950 stock, go to TipRanks’ Stock Analysis page.